Welcome to AAMC  

Mission

Patient Resources

Medical Uses

News

Recipes

Search

Message Board

Contribute

Links

Contact

 

Antiemetic effect of delta 9-tetrahydrocannabinol in chemotherapy-associated nausea and emesis as compared to placebo and compazine.

Orr LE, McKernan JF
J Clin Pharmacol 1981 Aug-Sep; 21(8-9 Suppl):76S-80S

Fifty-five patients harboring a variety of neoplasms and previously found to have severe nausea or emesis from antitumor drugs were given antiemetic prophylaxis in a double-blind, randomized crossover fashion. Delta 9-Tetrahydrocannabinol (THC), prochlorperazine, and placebo were compared. Nausea was absent in 40 of 55 patients receiving THC, in 8 of 55 patients receiving prochlorperazine, and in 5 of 55 in the placebo group. THC appeared to be more efficacious in controlling the emesis associated with cyclophosphamide, 5-fluorouracil, and doxorubicin and less so for nitrogen mustard and the nitrosourea. THC appears to offer significant control of nausea in most patients and exceeds by far that provided by prochlorperazine (P less than 0.005).

Cancer References: ACS : American Cancer Society

Medical References: National Library of Medicine - PubMed



Distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes.

     
   

Click here to refer this page to a friend and let freedom grow

Home | Mission | Patient Resources | News & Events | Recipes
Search | Message Board | Medical Uses | Contribute | Links | Contact


Copyright 2001-2007 American Alliance for Medical Cannabis, Inc. All rights reserved.